The cost-effectiveness of directly observed highly-active antiretroviral therapy in the third trimester in HIV-infected pregnant women.

The cost-effectiveness of directly observed highly-active antiretroviral therapy in the third trimester in HIV-infected pregnant women.

Item
http://www.wikidata.org/entity/Q33559823
A narrative review of cost-effectiveness analysis of people living with HIV treated with HAART: from interventions to outcomesThe cost-effectiveness of different feeding patterns combined with prompt treatments for preventing mother-to-child HIV transmission in South Africa: estimates from simulation modeling.Costs and cost-effectiveness of training traditional birth attendants to reduce neonatal mortality in the Lufwanyama Neonatal Survival study (LUNESP).Individual-based simulation models of HIV transmission: reporting quality and recommendations.Adherence with drug therapy in pregnancyPrevention, Rehabilitation, and Mitigation Strategies of Cognitive Deficits in Aging with HIV: Implications for Practice and ResearchAcceptability and feasibility of mHealth and community-based directly observed antiretroviral therapy to prevent mother-to-child HIV transmission in South African pregnant women under Option B+: an exploratory study.Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis.Cost-effectiveness of adherence interventions for highly active antiretroviral therapy: a systematic review.Costs and cost-effectiveness of HIV community services: quantity and quality of studies published 1986-2011.Cost-effectiveness of adherence-enhancing interventions: a systematic review.What we know and what we do not know about factors associated with and interventions to promote antiretroviral adherence.Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.Does directly administered antiretroviral therapy represent good value for money in sub-Saharan Africa? A cost-utility and value of information analysis.Universal Rapid Human Immunodeficiency Virus Screening at Delivery: A Cost-Effectiveness Analysis.Successful prevention of perinatal HIV transmission utilizing direct observation therapy in the setting of Acquired Immunodeficiency Syndrome (AIDS) and progressive multifocal leukoencephalopathy
P2860

The cost-effectiveness of directly observed highly-active antiretroviral therapy in the third trimester in HIV-infected pregnant women.

Item
http://www.wikidata.org/entity/Q33559823
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The cost-effectiveness of dire ...... n HIV-infected pregnant women.
@ast
The cost-effectiveness of dire ...... n HIV-infected pregnant women.
@en
The cost-effectiveness of dire ...... n HIV-infected pregnant women.
@nl
type
label
The cost-effectiveness of dire ...... n HIV-infected pregnant women.
@ast
The cost-effectiveness of dire ...... n HIV-infected pregnant women.
@en
The cost-effectiveness of dire ...... n HIV-infected pregnant women.
@nl
prefLabel
The cost-effectiveness of dire ...... n HIV-infected pregnant women.
@ast
The cost-effectiveness of dire ...... n HIV-infected pregnant women.
@en
The cost-effectiveness of dire ...... n HIV-infected pregnant women.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
The cost-effectiveness of dire ...... n HIV-infected pregnant women.
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0010154
P407
P433
P478
P50
P577
P5875
P698
P921
P932